European Pharmaceutical Review

JANUARY 18, 2024

Comparatively, in 2015, GlobalData’s research expected that sales of therapies for Gaucher disease will reach $1.16 GlobalData anticipated it will launch in the US and 5EU (France, Germany, Italy, Spain, and the UK) markets during the forecast period, Sulayman Patel, MSci, Pharma Analyst at GlobalData noted. “As billion by 2024.

Marketing 98

Marketing Sales Pharmacology Pharma 98

Pharmaceutical Technology

OCTOBER 10, 2022

After more than a decade in development, Freya Pharma Solutions plans to advance an oral tablet dubbed Lybrido into Phase III trials to treat female sexual interest/arousal disorder (FSIAD). Moreover, despite the buzz generated when Addyi was launched in 2015, only one other drug has since been marketed.

Pharmacology 59

Pharmacology Side effects FDA Safety 59

European Pharmaceutical Review

FEBRUARY 14, 2024

Firstly, the pharmacological response to LBPs does not follow traditional pharmacokinetic principles. About the authors Mike Frodsham has been the Chief Technical Officer for SGS Quay Pharma for over 18 years and holds over 23 years of experience in drug product development. 2015; 69(1):381–403 5. 2021; 19:100306 4.

Food and Drug Administration 97

Food and Drug Administration Manufacturing Engineering Pharmacology 97

pharmaphorum

JANUARY 16, 2023

Across swathes of primary care, pharmacological innovation has stalled; the last new antihypertensive class was introduced in 2007 and new antibiotics have trickled in at a dangerously slow pace. To thrive, pharma must ask increasingly tough questions about the viability of candidates for clinical development.

FDA 98

FDA Healthcare Healthcare Medicine 98